STIMNeuronetics, Inc.

Nasdaq neurostar.com


$ 2.56 $ -0.05 (-1.92 %)    

Wednesday, 08-May-2024 15:58:39 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 2.55
$ 2.59
$ 0.00 x 0
$ 2.58 x 200
$ 2.53 - $ 2.65
$ 1.03 - $ 5.07
189,924
na
75.15M
$ 1.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-08-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 03-02-2021 12-31-2020 10-K
15 11-02-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 03-03-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-05-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 neuronetics-q1-eps-027-beats-034-estimate-sales-1742m-beat-1712m-estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.31) b...

 neuronetics-inc-announces-new-publication-in-brain-stimulation-confirms-full-tms-treatment-course-is-vital

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that imp...

 top-5-health-care-stocks-that-may-plunge-in-march

As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as...

 why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

 neuronetics-q4-gaap-eps-019-beats-026-estimate-sales-2031m-beat-1985m-estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.26) b...

 earnings-scheduled-for-march-5-2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

 earnings-outlook-for-neuronetics
Earnings Outlook For Neuronetics
03/04/2024 18:02:28

 neuronetics-reports-fy23-preliminary-unaudited-total-revenue-is-expected-to-be-over-71m-as-compared-to-previously-stated-guidance-of-70m-72m

Full Year 2023Preliminary unaudited total revenue is expected to be over $71 million as compared to previously stated guidance ...

 neuronetics-receives-fda-510k-clearance-for-neurosite-coil-placement-accessory-that-simplifies-measurement-and-coil-positioning-during-neurostar-transcranial-magnetic-stimulation-treatments

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that imp...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION